Safety review update of Revlimid and risk of developing new types of malignancies October 03, 2017Vol.40 No.08
Two Opdivo trials show three-year survival in patients with previously treated advanced NSCLC October 03, 2017Vol.40 No.08
Drugs & Targets FDA approves treatment to reduce risk of breast cancer returning August 03, 2017Vol.40 No.07
Experimental “enhancer” may boost conventional therapies for pediatric disease August 03, 2017Vol.40 No.07
Combined molecular biology test can identify patients with benign pancreatic abnormalities August 03, 2017Vol.40 No.07
Differences in subtypes may determine prognosis and response to treatment August 03, 2017Vol.40 No.07
UW study links insurance coverage to higher rates of colorectal cancer screenings August 03, 2017Vol.40 No.07
First-line immunotherapy treatment can improve survival for subset of lung cancer patients August 03, 2017Vol.40 No.07
